MarketCap
Facebook
X
Telegram
Amedisys EBITDA | AMED
Earnings before Interest, Taxes, Depreciation, and Amortization (EBITDA), is an often used measure of a company's profitability. Financial analysts use EBITDA for a number of purposes including calculating simple valuations of a firm, estimating cash flows, and assessing debt servicing capability. The uses for EBITDA in financial analysis are numerous, but in practice should be more restrained. While EBITDA has some useful applications, it should be used with caution, as the problems with EBITDA are abundant and can lead to a number of misguided conclusions.[1]
EBITDA is an important indicator for investors and analysts because it allows them to evaluate a company's operating profit without considering the impact of financial expenses, taxes, or non-cash depreciation and amortization. It provides better comparability between companies in different industries or with different tax conditions.
EBITDA is often used to assess a company's ability to generate cash flow and repay debts. It can also serve as a measure of a company's operational efficiency, as it shows how profitable the core business is, regardless of external factors such as interest or taxes.
However, it is important to note that EBITDA is not an official financial statement measure and can be defined and calculated differently by companies. Therefore, investors and analysts should exercise caution when using EBITDA as an evaluation tool and combine it with other financial metrics and information to get a more complete picture of a company's financial condition.
Annual EBITDA Amedisys
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121 M | 180 M | 206 M | 283 M | 248 M | 197 M | 168 M | 126 M | 81.4 M | 88.1 M | 55.5 M | 41.4 M | 89.8 M | -432 M | 246 M | 262 M | 178 M | 110 M | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 283 M | -432 M | 125 M |
Quarterly EBITDA Amedisys
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | 2010-Q2 | 2010-Q1 | 2009-Q3 | 2009-Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 59.1 M | 50.1 M | - | 35.1 M | 56.6 M | 37.8 M | - | 46.6 M | 42.5 M | 48.1 M | - | 44.4 M | 53.9 M | 56 M | - | 78.5 M | 84.9 M | 76.4 M | - | 83.3 M | 61.6 M | 49.2 M | - | 59.3 M | 52.8 M | 47.2 M | - | 49.8 M | 49.5 M | 39.6 M | - | 36.5 M | 9.19 M | 29.6 M | - | 29 M | 27.8 M | 15.5 M | - | 32.5 M | 26.7 M | -51.6 M | - | 38.4 M | 28.2 M | -11.6 M | - | -125 M | 23.9 M | 15.5 M | - | 45.4 M | 35.4 M | 22.6 M | - | -526 M | 59.1 M | 39.5 M | 45.9 M | 64.4 M | 69.9 M | 68.2 M | 66.5 M |
Quarterly performance
Select metrics to display
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 84.9 M | -526 M | 28.1 M |
References
- Brockman, C. M., & Russell, J. W. (2012). EBITDA: use it... or lose it?. International Journal of Business, Accounting and Finance, 6(2), 84-93.
EBITDA of other stocks in the Care facilities industry
| Issuer | EBITDA | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
IMAC Holdings
IMAC
|
-5.48 M | - | -1.77 % | $ 25.4 M |  USA |
 |
ModivCare
MODV
|
16.7 M | - | -25.23 % | $ 6.12 M | USA |
 |
DaVita
DVA
|
2.75 B | $ 179.27 | -3.38 % | $ 13.3 B | USA |
 |
HCA Healthcare
HCA
|
3.52 B | $ 504.51 | -0.09 % | $ 119 B | USA |
 |
Chemed Corporation
CHE
|
403 M | $ 544.61 | 1.22 % | $ 7.84 B | USA |
 |
National HealthCare Corporation
NHC
|
173 M | $ 209.19 | -0.26 % | $ 3.24 B | USA |
 |
Option Care Health
OPCH
|
405 M | $ 31.65 | -0.14 % | $ 5.13 B | USA |
 |
Surgery Partners
SGRY
|
566 M | $ 26.76 | 1.15 % | $ 3.4 B | USA |
 |
Sanara MedTech
SMTI
|
11.3 M | $ 31.66 | -1.37 % | $ 273 M | USA |
 |
Tenet Healthcare Corporation
THC
|
4.37 B | $ 290.64 | 0.57 % | $ 26.2 B | USA |
 |
SunLink Health Systems
SSY
|
-1.04 M | - | 17.98 % | $ 7.81 M | USA |
 |
Universal Health Services
UHS
|
2.61 B | $ 195.47 | -0.86 % | $ 12.4 B | USA |
 |
Мать и Дитя
MDMG
|
8.13 B | - | - | - |  Russia |
 |
Tivity Health
TVTY
|
154 M | - | 0.09 % | $ 1.6 B | USA |
 |
LHC Group
LHCG
|
132 M | - | - | $ 5.27 B | USA |
 |
AMN Healthcare Services
AMN
|
101 M | $ 37.77 | 0.16 % | $ 1.45 B | USA |
 |
Oak Street Health
OSH
|
-97 M | - | 0.03 % | $ 9.53 B | USA |
 |
Ontrak
OTRK
|
-17.2 M | - | -11.98 % | $ 1.53 M | USA |
 |
Hanger
HNGR
|
105 M | - | - | $ 732 M | USA |
|
Novo Integrated Sciences
NVOS
|
-7.81 M | - | -13.87 % | $ 1.52 M | USA |
 |
American Shared Hospital Services
AMS
|
2.13 M | $ 1.2 | -2.44 % | $ 7.94 M | USA |
 |
Community Health Systems
CYH
|
1.91 B | $ 2.17 | -3.76 % | $ 290 M | USA |
 |
Fresenius Medical Care AG & Co. KGaA
FMS
|
3.33 B | $ 22.74 | -0.92 % | $ 6.62 B |  Germany |
 |
Brookdale Senior Living
BKD
|
384 M | $ 9.18 | -1.4 % | $ 2.16 B | USA |
 |
Acadia Healthcare Company
ACHC
|
189 M | $ 38.71 | 0.25 % | $ 3.51 B | USA |
 |
Addus HomeCare Corporation
ADUS
|
155 M | $ 126.57 | 3.39 % | $ 2.28 B | USA |
 |
Capital Senior Living Corporation
CSU
|
-235 M | - | -2.09 % | $ 216 M | USA |
 |
COMPASS Pathways plc
CMPS
|
-179 M | $ 9.25 | 0.76 % | $ 865 M |  Britain |
 |
Elanco Animal Health Incorporated
ELAN
|
680 M | $ 27.0 | 0.6 % | $ 13.4 B | USA |
 |
Concord Medical Services Holdings Limited
CCM
|
-158 M | $ 3.68 | 0.55 % | $ 482 M |  China |
 |
Encompass Health Corporation
EHC
|
328 M | $ 142.58 | 1.01 % | $ 14.3 B | USA |
 |
Healthcare Services Group
HCSG
|
16.8 M | $ 25.29 | 2.06 % | $ 1.83 B | USA |
|
New Frontier Health Corporation
NFH
|
354 M | - | 3.54 % | $ 1.5 B | USA |
 |
The Joint Corp.
JYNT
|
2.46 M | $ 6.84 | 2.86 % | $ 104 M | USA |
 |
MEDNAX
MD
|
231 M | $ 31.63 | 0.44 % | $ 2.66 B | USA |
 |
Phibro Animal Health Corporation
PAHC
|
246 M | $ 34.64 | 0.09 % | $ 1.4 B | USA |
 |
The Pennant Group
PNTG
|
60.4 M | $ 36.8 | 1.48 % | $ 1.27 B | USA |
|
Aesthetic Medical International Holdings Group Limited
AIH
|
53.3 M | - | 10.96 % | $ 46.2 M | China |
 |
Five Star Senior Living Inc.
FVE
|
26.9 M | - | -0.32 % | $ 98.4 M | USA |
 |
U.S. Physical Therapy
USPH
|
109 M | $ 99.36 | -0.48 % | $ 1.51 B | USA |
 |
Genesis Healthcare, Inc.
GEN
|
-162 M | - | - | $ 68.1 M | USA |
 |
Avalon GloboCare Corp.
AVCO
|
-7.5 M | - | 26.45 % | $ 70.6 M | USA |
 |
Apollo Medical Holdings
AMEH
|
124 M | - | -2.11 % | $ 1.84 B | USA |
 |
The Ensign Group
ENSG
|
530 M | $ 185.09 | 1.64 % | $ 10.6 B | USA |
 |
Regional Health Properties
RHE
|
3.73 M | - | - | $ 5.2 M | USA |
 |
Select Medical Holdings Corporation
SEM
|
476 M | - | - | $ 2.02 B | USA |